FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sandro Fenu

Research Profile

Living Beings

Chemicals & Drugs

Activities & Behaviors

Co-author Network

Publications

TOP 3
Nicola Simola; Giulia Costa; Sandro Fenu; Annalisa Pinna; A Plumitallo; Micaela Morelli
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward.
Gaetano Di Chiara; Valentina Valentini; Sandro Fenu
Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement.
Sandro Fenu; Cristina Cadoni; GAETANO DI CHIARA
Conditioned saccharin avoidance and sensitization to drugs of abuse.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sandro Fenu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Nicola Simola; Giulia Costa; Sandro Fenu; Annalisa Pinna; A Plumitallo; Micaela Morelli
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward.
Neuropharmacology 2012;63(2):224-34.
2011: Gaetano Di Chiara; Valentina Valentini; Sandro Fenu
Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement.
International review of neurobiology 2011;96():111-39.
2010: Sandro Fenu; Cristina Cadoni; GAETANO DI CHIARA
Conditioned saccharin avoidance and sensitization to drugs of abuse.
Behavioural brain research 2010;214(2):248-53.
2010: Nicola Simola; Annalisa Pinna; Sandro Fenu
Pharmacological therapy of Parkinson's disease: current options and new avenues.
Recent patents on CNS drug discovery 2010;5(3):221-38.
2009: Sandro Fenu; Jadwiga Wardas; Micaela Morelli
Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
Behavioural pharmacology 2009;20(5-6):363-79.
2008: Nicola Simola; Sandro Fenu; Pier G Baraldi; Mojgan Aghazadeh Tabrizi; Micaela Morelli
Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
Synapse (New York, N.Y.) 2008;62(5):345-51.
2006: Nicola Simola; Sandro Fenu; Pier G Baraldi; Mojgan Aghazadeh Tabrizi; Micaela Morelli
Involvement of globus pallidus in the antiparkinsonian effects of adenosine A(2A) receptor antagonists.
Experimental neurology 2006;202(1):255-7.
2006: Nicola Simola; Sandro Fenu; Pier G Baraldi; Mojgan Aghazadeh Tabrizi; Micaela Morelli
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.
Journal of the neurological sciences 2006;248(1-2):48-52.
2006: Sandro Fenu; Liliana Spina; Emilia Rivas; Rosanna Longoni; GAETANO DI CHIARA
Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression.
Psychopharmacology 2006;187(2):143-53.
2006: Adolfo Pisanu; Elio Acquas; Sandro Fenu; GAETANO DI CHIARA
Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
Neuropharmacology 2006;50(6):661-70.
2006: Liliana Spina; Sandro Fenu; Rosanna Longoni; Emilia Rivas; GAETANO DI CHIARA
Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition.
Psychopharmacology 2006;184(3-4):447-55.
2005: Sandro Fenu; Emilia Rivas; GAETANO DI CHIARA
Differential role of dopamine in drug- and lithium-conditioned saccharin avoidance.
Physiology & behavior 2005;85(1):37-43.
2004: Nicola Simola; Sandro Fenu; Pier G Baraldi; Mojgan Aghazadeh Tabrizi; Micaela Morelli
Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions.
Experimental neurology 2004;189(1):182-8.
2004: GAETANO DI CHIARA; Valentina Bassareo; Sandro Fenu; Maria Antonietta De Luca; Liliana Spina; Cristina Cadoni; Elio Acquas; Ezio Carboni; Valentina Valentini; Daniele Lecca
Dopamine and drug addiction: the nucleus accumbens shell connection.
Neuropharmacology 2004;47 Suppl 1():227-41.
2003: Anna R Carta; Sandro Fenu; P Pala; Elisabetta Tronci; Micaela Morelli
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats.
The European journal of neuroscience 2003;18(9):2563-72.
2003: Sandro Fenu; GAETANO DI CHIARA
Facilitation of conditioned taste aversion learning by systemic amphetamine: role of nucleus accumbens shell dopamine D1 receptors.
The European journal of neuroscience 2003;18(7):2025-30.
2001: Sandro Fenu; Valentina Bassareo; GAETANO DI CHIARA
A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(17):6897-904.
2001: Annalisa Pinna; Sandro Fenu; Micaela Morelli
Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
Synapse (New York, N.Y.) 2001;39(3):233-8.
2001: Sandro Fenu; Elio Acquas; GAETANO DI CHIARA
Role of striatal acetylcholine on dopamine D1 receptor agonist-induced turning behavior in 6-hydroxydopamine lesioned rats: a microdialysis-behavioral study.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2001;22(1):63-4.
2001: Anna R Carta; Sandro Fenu; Micaela Morelli
Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson's disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2001;22(1):59-60.
2000: Sandro Fenu; Omar Cauli; Micaela Morelli
Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A(2A) receptors.
Behavioural brain research 2000;114(1-2):97-105.
1999: Elio Acquas; Sandro Fenu; P Loddo; GAETANO DI CHIARA
A within-subjects microdialysis/behavioural study of the role of striatal acetylcholine in D1-dependent turning.
Behavioural brain research 1999;103(2):219-28.
1999: GAETANO DI CHIARA; Gianluigi Tanda; Valentina Bassareo; Francesco E Pontieri; Elio Acquas; Sandro Fenu; Cristina Cadoni; Ezio Carboni
Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine.
Annals of the New York Academy of Sciences 1999;877():461-85.
1998: Sandro Fenu; Micaela Morelli
Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors.
The European journal of neuroscience 1998;10(5):1878-84.
1997: Sandro Fenu; Annalisa Pinna; E Ongini; Micaela Morelli
Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.
European journal of pharmacology 1997;321(2):143-7.
1996: Micaela Morelli; Sandro Fenu; Antonio Carta; GAETANO DI CHIARA
Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen.
Behavioural brain research 1996;79(1-2):93-100.
1995: Sandro Fenu; Antonio Carta; Micaela Morelli
Modulation of dopamine D1-mediated turning behavior and striatal c-fos expression by the substantia nigra.
Synapse (New York, N.Y.) 1995;19(4):233-40.
1995: Sandro Fenu; Antonio Carta; Micaela Morelli
Intranigral injections of glutamate antagonists modulate dopamine D1-mediated turning behavior and striatal c-fos expression.
Journal of neural transmission. Supplementum 1995;45():75-81.
1994: Micaela Morelli; Annalisa Pinna; Sandro Fenu; Antonio Carta; A Cozzolino; GAETANO DI CHIARA
Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats.
Synapse (New York, N.Y.) 1994;18(4):288-93.
1994: Micaela Morelli; Sandro Fenu; Annalisa Pinna; GAETANO DI CHIARA
Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats.
European journal of pharmacology 1994;251(1):21-5.
1993: Micaela Morelli; A Cozzolino; Annalisa Pinna; Sandro Fenu; Antonio Carta; GAETANO DI CHIARA
L-dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors.
Brain research 1993;623(2):334-6.
1993: Micaela Morelli; Sandro Fenu; A Cozzolino; Annalisa Pinna; Antonio Carta; GAETANO DI CHIARA
Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses.
Neuroscience 1993;53(3):673-8.
1992: Micaela Morelli; Sandro Fenu; GAETANO DI CHIARA
Blockade of N-methyl-D-aspartate receptors potentiates dopaminergic responses in the 6-OHDA model of Parkinson: differential role of D-1 and D-2 receptors.
Neurochemistry international 1992;20 Suppl():261S-264S.
1992: Micaela Morelli; Sandro Fenu; Annalisa Pinna; GAETANO DI CHIARA
Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
The Journal of pharmacology and experimental therapeutics 1992;260(1):402-8.
1991: Micaela Morelli; Sandro Fenu; A Cozzolino; GAETANO DI CHIARA
Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of Parkinsonism: role of priming.
Neuroscience 1991;42(1):41-8.
1989: Micaela Morelli; Sandro Fenu; GAETANO DI CHIARA
Substantia nigra as a site of origin of dopamine-dependent motor syndromes induced by stimulation of mu and delta opioid receptors.
Brain research 1989;487(1):120-30.
1989: Micaela Morelli; Sandro Fenu; L Garau; GAETANO DI CHIARA
Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity.
European journal of pharmacology 1989;162(2):329-35.